Pulmonary Embolism in COVID-19 Patients: Awareness of an Increased Prevalence.
暂无分享,去创建一个
S. Susen | A. Rauch | J. Labreuche | J. Poissy | E. Jeanpierre | T. Duburcq | F. Lassalle | Julien Goutay | Morgan Caplan | E. Parmentier | Fanny Lassalle
[1] anonymous,et al. High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) Requiring Invasive Mechanical Ventilation , 2020, Obesity.
[2] J. Thachil,et al. The versatile heparin in COVID‐19 , 2020, Journal of Thrombosis and Haemostasis.
[3] T. Wakefield,et al. Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients. , 2019, Journal of vascular surgery. Venous and lymphatic disorders.
[4] F. Dentali,et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. , 2018, Blood advances.
[5] Elie A Akl,et al. Prevention of VTE in Nonsurgical Patients Antithrombotic Therapy and Prevention of Thrombosis , 9 th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines , 2013 .